FDA trial shows sustained effect for Ozurdex on diabetic

FDA trial shows sustained effect for Ozurdex on diabetic

The dexamethasone intraocular implant OZURDEX® (Allergan)

can bring about significant and visual improvement in patients

with diabetic macular oedema, with generally only transient

increases in IOP but with a high incidence of cataract in

phakic patients, said EURETINA president ,Francesco

Bandello MD, told attendees at an EURETINA free paper

session

He reported the pooled  results of two FDA studies conducted

by the MEAD study group involving a total of 1048 patients 

with diabetic macular oedema. The patients were randomised

into three groups to receive Ozurdex at a dosage of 0.7 mg  or

0.35 mg , or sham treatment, with repeated injections when

indicated at intervals no shorter than six months.

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...